Alliancebernstein L.P. Chemo Centryx, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

Shares

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 15, 2022	BUY	$22.17 - $51.8 $11.4 Million - $26.6 Million	512,713 Added 679.09%	588,213 $30.4 Million
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $201,216 - $360,381	13,100 Added 20.99%	75,500 $1.87 Million
Q1 2022 May 13, 2022	BUY	$22.22 - $39.12 $2,222 - $3,911	100 Added 0.16%	62,400 $1.56 Million
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $18,380 - $40,500	-1,000 Reduced 1.58%	62,300 $2.27 Million
Q3 2021 Nov 10, 2021	SELL	$13.18 - $19.83 $98,850 - $148,725	-7,500 Reduced 10.59%	63,300 $1.08 Million
Q2 2021 Jul 30, 2021	SELL	$9.59 - $50.88 $254,528 - $1.35 Million	-26,541 Reduced 27.27%	70,800 $948,000
Q1 2021 May 06, 2021	BUY	$49.53 - $68.4 $29,718 - $41,040	600 Added 0.62%	97,341 $4.99 Million
Q4 2020 Feb 08, 2021	SELL	$47.25 - $65.16 $297,675 - $410,508	-6,300 Reduced 6.11%	96,741 $5.99 Million
Q3 2020 Nov 12, 2020	SELL	$46.35 - $61.69 $488,482 - $650,150	-10,539 Reduced 9.28%	103,041 $5.65 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $65.07 $420,522 - $709,262	10,900 Added 10.62%	113,580 $6.54 Million
Q1 2020 May 14, 2020	BUY	$32.73 - $50.78 $475,566 - $737,833	14,530 Added 16.48%	102,680 $4.13 Million
Q4 2019 Feb 18, 2020	BUY	$6.81 - $39.55 $196,468 - $1.14 Million	28,850 Added 48.65%	88,150 $3.49 Million
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $106,368 - $190,080	12,800 Added 27.53%	59,300 $551,000
Q1 2019 May 14, 2019	SELL	$10.01 - $13.89 $2,002 - $2,778	-200 Reduced 0.43%	46,500 $646,000
Q2 2018 Aug 13, 2018	BUY	$10.62 - $13.98 $70,092 - $92,268	6,600 Added 16.46%	46,700 $615,000
Q1 2018 May 14, 2018	BUY	$5.9 - $14.99 $15,340 - $38,974	2,600 Added 6.93%	40,100 $545,000
Q3 2017 Nov 13, 2017	BUY	$6.5 - $10.69 $243,750 - $400,875	37,500	37,500 $278,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.